NEW YORK, Nov. 6, 2025 /PRNewswire/ -- Hone Health, the leader in longevity intelligence and personalized care, is teaming up with…
DOVER, Del., Nov. 6, 2025 /PRNewswire/ -- Mwyngil Therapeutics Inc., a biopharmaceutical company dedicated to developing first-in-class and best-in-class small-molecule therapies…
Held meeting with U.S. Food and Drug Administration (FDA) where, among other things, they reiterated October 2024 agreement to use…
Society for Neuroscience Annual Meeting, November 15-19, San Diego, CAWALTHAM, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sironax, a global…
The ballot measure was supported by national and local neurodegenerative disease organizations, including The Michael J. Fox Foundation (MJFF). MJFF…
JENKINTOWN, PA / ACCESS Newswire / November 5, 2025 / SarahCare Adult Day Center of Jenkintown is thrilled to announce…
This strategic filing with the FDA follows encouraging internal data and recent published studies supporting Nexalin’s frequency neurostimulator as a…
WESTBROOK, Maine, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR), a leading consumer health and wellness company,…
New NIH grant awards $2.5 million over 5 years for mechanistic studyBURLINGTON, Mass. and JERUSALEM, Nov. 04, 2025 (GLOBE NEWSWIRE)…
ATLAS GPT Brings Award-Winning Surgical Excellence to Transform Clinical Decision-Making Across All Healthcare Disciplines LOS ANGELES, Nov. 4, 2025 /PRNewswire/…